Qube Research & Technologies Ltd
- SEC CIK
- 0001729829
- Latest filing
- Aug 14, 2026
ADAPY holding history
Adaptimmune Therapeutics PLC in every 13F filed by Qube Research & Technologies Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ADAPY overviewAll 13F holders of ADAPYFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −10,113−100.0% | Sold out | Holders |
| Q1 2025 | 10,113 | $1.99K | <0.1% | +10,113 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −2,087−100.0% | Sold out | Holders |
| Q4 2023 | 2,087 | $1.66K | <0.1% | −19,474−90.3% | Reduced | Holders |
| Q3 2023 | 21,561 | $16.8K | <0.1% | −78,589−78.5% | Reduced | Holders |
| Q2 2023 | 100,150 | $92.6K | <0.1% | +52,326+109.4% | Added | Holders |
| Q1 2023 | 47,824 | $52.1K | <0.1% | +20,823+77.1% | Added | Holders |
| Q4 2022 | 27,001 | $39.4K | <0.1% | +27,001 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −43,966−100.0% | Sold out | Holders |
| Q2 2022 | 43,966 | $75.0K | <0.1% | +43,966 | New | Holders |